|
|
Line 1: |
Line 1: |
| [[Image:1sx2.jpg|left|200px]] | | {{Seed}} |
| | [[Image:1sx2.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1sx2| PDB=1sx2 | SCENE= }} | | {{STRUCTURE_1sx2| PDB=1sx2 | SCENE= }} |
|
| |
|
| '''Use of a Halide Binding Site to Bypass the 1000-atom Limit to Structure Determination by Direct Methods'''
| | ===Use of a Halide Binding Site to Bypass the 1000-atom Limit to Structure Determination by Direct Methods=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| Proteins with more than 1000 non-H atoms and without heavy-atom prosthetic groups are very difficult to solve by ab initio direct methods. T4 lysozyme is being used to explore these limits. The protein has 1309 non-H atoms, seven S atoms, no disulfide bonds and no heavy-atom prosthetic group. It is recalcitrant to structure determination by direct methods using X-ray diffraction data to 0.97 A. It is shown here that it is possible to obtain a truly ab initio structure determination of a variant of the protein that has an Rb+ (Z = 37) binding site. Using diffraction data to 1.06 A resolution, the direct-methods programs SIR2002 and ACORN independently solved the structure in about 20 h. The bound Rb+, which contributes about 1.7% of the total scattering, does not appear to distort the structure or to inhibit refinement (R factor 12.1%). The phases obtained via SIR2002 or ACORN are in good agreement with those from a reference structure obtained from conventional molecular-substitution and refinement procedures (average error in the figure-of-merit-weighted phases of less than 25 degrees). Thus, proteins with more than 1000 atoms that include halide-binding or other such sites may be amenable to structure determination by ab initio direct methods. The direct-methods approaches are also compared with structure determination via use of the anomalous scattering of the Rb+ ion. As shown by examples, high-resolution structures determined by direct methods can be useful in highlighting regions of strain in the protein, including short hydrogen bonds and non-planar peptide groups.
| | The line below this paragraph, {{ABSTRACT_PUBMED_15388918}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 15388918 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_15388918}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
Line 27: |
Line 31: |
| [[Category: Ab initio direct method]] | | [[Category: Ab initio direct method]] |
| [[Category: Rb+ binding site]] | | [[Category: Rb+ binding site]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:14:12 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 11:48:31 2008'' |